General health versus tumor stage: determinants of survival in Merkel cell carcinoma assessed by sentinel lymph node biopsy
Authors:
- Thilo GambichlerTGThilo Gambichler
- Nessr Abu RachedNessr Abu Rached
- Hans-Joachim SchulzeHans-Joachim Schulze
- Kirsten NoahKNKirsten Noah
- Silke C. HofmannSHSilke C. Hofmann
- Ulrich WesselmannUWUlrich Wesselmann
- Ralf GutzmerRalf Gutzmer
- Stefanie BomsSBStefanie Boms
- Laura SusokLSLaura Susok
- Sera S. Weyer-FahlbuschSWSera S. Weyer-Fahlbusch
- Alexander KreuterAlexander Kreuter
Open Access
- 28 April 2026
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 152 (4) , 100
Abstract
Purpose: Overall survival (OS) of Merkel cell carcinoma (MCC) patients is strongly influenced by health. Sentinel lymph node biopsy (SLNB) is recommended for staging. We evaluated whether SLNB is associated with OS in clinically node-negative MCC and contrasted tumor factors with patient frailty. Methods: STROBE-compliant cohort across eight centers in Germany (2004–2024). We included 271 primary stage I–II MCC; 167 underwent SLNB and 104 did not. The primary outcome was OS; disease-specific survival (DSS) and progression-free probability (PFP) were secondary. Kaplan–Meier and Cox models were used. Confounding by indication was addressed with 1:1 propensity score matching and sensitivity analyses. Results: Patients receiving SLNB were younger (median 74 vs 82 years; p < 0.001) and less comorbid (Charlson 4 vs 5). Ten-year OS was 69.5% with SLNB versus 45.2% without (log-rank p < 0.0001); unadjusted HR 0.34 (95% CI 0.20–0.59). In the matched cohort, SLNB remained associated with lower all-cause mortality (HR 0.56, 95% CI 0.34–0.93; p = 0.024). DSS did not differ (HR 1.09, 95% CI 0.55–2.13; p = 0.81). For PFP, unadjusted curves favored SLNB ( p =0.0045), but the matched analysis was not significant (HR 0.53, 95% CI 0.23–1.26). Sensitivity analyses suggested benefit: overlap weighting HR 0.49 (95% CI 0.33–0.73; p = 0.00045) and a stage-restricted match HR 0.36 (95% CI 0.13–0.99; p = 0.048). Conclusions: SLNB was associated with improved OS after adjustment, supporting its role in staging and risk stratification. The absence of DSS and matched PFP differences highlights the influence of overall health; residual confounding by indication cannot be excluded.Keywords
All Related Versions
Funding Information
- Private Universität Witten/Herdecke gGmbH
This publication has 32 references indexed in Scilit:
- Sentinel lymph node biopsy in Merkel cell carcinoma: Predictors of sentinel lymph node positivity and association with overall survivalJournal of the American Academy of Dermatology, 2019
- Sentinel lymph node biopsy in clinically node‐negative Merkel cell carcinoma: the Westmead Hospital experienceAnz Journal of Surgery, 2019
- Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?Annals of Surgical Oncology, 2018
- Investigation of the Diagnostic Precision and Utility of Sentinel Lymph Node Biopsy in the Treatment of Patients with Merkel Cell CarcinomaThe American Surgeon™, 2018
- Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patientsLaboratory Investigation, 2016
- Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinomaCancer, 2015
- Prognostic Significance of Sentinel Lymph Node Mapping in Merkel Cell Carcinoma: Systematic Review and Meta-Analysis of Prognostic StudiesBioMed Research International, 2014
- Sentinel lymph node in Merkel cell carcinoma: To biopsy or not to biopsy?The Journal of Dermatology, 2013
- Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice GuidelineJournal of Clinical Oncology, 2012
- Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodesJournal of the American Academy of Dermatology, 2002